MorphoSys AG (MOR) Financials
Stock symbol MOR is outdated, potentially delisted? Maybe it is available on other exchange?
MOR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2024 | 2.0 billion | 2.3 billion |
| Dec. 31, 2023 | 2.2 billion | 2.2 billion |
| Sept. 30, 2023 | 2.2 billion | 2.3 billion |
| June 30, 2023 | 2.3 billion | 2.3 billion |
MOR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2024 | -69.6 million | 124.0 million |
| Dec. 31, 2023 | -63.1 million | 11.6 million |
| Sept. 30, 2023 | -37.4 million | 4.3 million |
| June 30, 2023 | -137.1 million | 11.8 million |
MOR Net Income
No data available :(
MOR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2024 | 680.8 million | 266.2 million | 9.2 million |
| Dec. 31, 2023 | 754.8 million | 687.5 million | 13.7 million |
| Sept. 30, 2023 | 678.6 million | 256.4 million | 37.6 million |
| June 30, 2023 | 730.4 million | 300.0 million | 43.4 million |
MOR Shares Outstanding
MOR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2024 | 52010 | 91.9 million | 219.0 million | 19.9 million |
| Dec. 31, 2023 | 763841 | 88.8 million | -10.1 million | -58.0 million |
| Sept. 30, 2023 | 1.8 million | 66.9 million | 36.9 million | 21.1 million |
| June 30, 2023 | 111013 | 62.0 million | 42.4 million | 23.9 million |
MOR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2024 | 29.7 million | 4.2 million |
| Dec. 31, 2023 | 65.3 million | 16.1 million |
| Sept. 30, 2023 | 67.5 million | 16.0 million |
| June 30, 2023 | 57.8 million | 8.4 million |
MOR
Price: $18.96
52 week price:
Earnings Per Share: -1.50 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 71900
Market Capitalization: 2.9 billion